SMTL ID : 1u65.1

Ache W. CPT-11

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.61 Å

Oligo State

homo-dimer

Ligands

2 x NAG- FUL: beta-L-fucopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-FUL.1: 3 residues within 4Å: Chain A: E.455, N.457 Ligands: NAG-MAN.3 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.457 NAG-FUL.8: 3 residues within 4Å: Chain B: E.455, N.457 Ligands: NAG-MAN.10 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:N.457

2 x NAG- FUC: alpha-L-fucopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-FUC.2: 3 residues within 4Å: Chain A: N.59, S.61, T.62 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:N.59, A:S.61, A:T.62 NAG-FUC.9: 3 residues within 4Å: Chain B: N.59, S.61, T.62 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:N.59, B:S.61, B:T.62, B:T.62, B:T.62

2 x NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)

NAG-MAN.3: 7 residues within 4Å: Chain A: N.429, V.431, E.455, L.456, N.457, Y.458 Ligands: NAG-FUL.1 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:N.457, A:N.429, A:Y.458 Water bridges: A:Y.458, A:Y.458 NAG-MAN.10: 7 residues within 4Å: Chain B: N.429, V.431, E.455, L.456, N.457, Y.458 Ligands: NAG-FUL.8 3 PLIP interactions: 3 interactions with chain B Hydrogen bonds: B:N.457, B:N.429, B:Y.458, B:Y.458

4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-functional Binders)(Post Translational Modification)

NAG.4: 1 residues within 4Å: Ligands: NAG.5 No protein-ligand interaction detected (PLIP) NAG.5: 4 residues within 4Å: Chain A: G.415, N.416, L.494 Ligands: NAG.4 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:L.494 Hydrogen bonds: A:N.416 Water bridges: A:N.416, A:N.416 NAG.11: 1 residues within 4Å: Ligands: NAG.12 No protein-ligand interaction detected (PLIP) NAG.12: 4 residues within 4Å: Chain B: G.415, N.416, L.494 Ligands: NAG.11 4 PLIP interactions: 4 interactions with chain B Hydrophobic interactions: B:L.494 Hydrogen bonds: B:N.416 Water bridges: B:N.416, B:N.416

2 x CP0: (4S)-4,11-DIETHYL-4-HYDROXY-3,14-DIOXO-3,4,12,14-TETRAHYDRO-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLIN-9-YL 1,4'-BIPIPERIDINE-1'-CARBOXYLATE(Non-covalent)

CP0.6: 14 residues within 4Å: Chain A: Y.70, Q.74, W.84, Y.121, E.199, W.279, L.282, F.284, D.285, S.286, F.330, F.331, Y.334, H.440 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:Y.70, A:W.84, A:W.84, A:W.279, A:D.285, A:F.330 Hydrogen bonds: A:Y.121, A:W.279, A:D.285 pi-Stacking: A:W.279, A:W.279, A:W.279 CP0.13: 14 residues within 4Å: Chain B: Y.70, Q.74, W.84, Y.121, E.199, W.279, L.282, F.284, D.285, S.286, F.330, F.331, Y.334, H.440 10 PLIP interactions: 10 interactions with chain B Hydrophobic interactions: B:Y.70, B:W.84, B:W.84, B:W.279, B:D.285, B:F.330 Hydrogen bonds: B:W.279 pi-Stacking: B:W.279, B:W.279, B:W.279

2 x IOD: IODIDE ION(Non-functional Binders)

IOD.7: 2 residues within 4Å: Chain A: H.264, E.268 Ligand excluded by PLIP IOD.14: 2 residues within 4Å: Chain B: H.264, E.268 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Harel, M. et al., The crystal structure of the complex of the anticancer prodrug 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothecin (CPT-11) with Torpedo californica acetylcholinesterase provides a molecular explanation for its cholinergic action. Mol.Pharmacol. (2005)

Release Date

2005-07-19

Peptides

Acetylcholinesterase: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

Acetylcholinesterase

Related Entries With Identical Sequence